Browsing Tag
City of Hope
5 posts
Can Diakonos make personalized melanoma cell therapy work without toxic conditioning?
Diakonos begins DOC1021 melanoma dosing as its outpatient cell therapy challenges intensive treatment and tests patient-specific manufacturing.
August 2, 2026
Thalia Therapeutics (AIM: THAT) completes Sanmirna acquisition to add Phase 1 AML asset
Thalia Therapeutics has completed its acquisition of Sanmirna Therapeutics, adding the Phase 1 miRisten programme for relapsed or refractory acute myeloid leukaemia. The deal accelerates Thalia’s transition into clinical-stage RNA therapeutics, but more than doubles its share count and leaves future value dependent on safety data, early biological evidence and further financing.
July 19, 2026
Thalia Therapeutics (AIM: THAT) shares jump 17% as Sanmirna deal adds Phase 1 AML asset
Thalia Therapeutics has agreed to acquire Sanmirna Therapeutics and its Phase 1 acute myeloid leukaemia drug miRisten, while raising £2.75 million to fund clinical data expected in 2027.
June 24, 2026
City of Hope researchers unveil thymus regeneration therapy for immune system repair
Scientists at City of Hope, one of the most renowned cancer research and treatment institutions in the United…
February 2, 2025
City of Hope Newport Beach opens for cancer treatment in Orange County, CA
City of Hope Newport Beach : City of Hope, a National Cancer Institute-designated comprehensive cancer center, has inaugurated…
January 29, 2020